[Federal Register Volume 80, Number 105 (Tuesday, June 2, 2015)]
[Notices]
[Page 31381]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13312]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following federal advisory committee 
meeting.
    Times and dates:

8:00 a.m.-5:15 p.m., June 24, 2015
8:30 a.m.-3:30 p.m., June 25, 2015
    Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton 
Road NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 
30333
    Status: Open to the public, limited only by the space available. 
Time will be available for public comment. The public is welcome to 
submit written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt is June 22, 2015. All requests must contain the 
name, address, and organizational affiliation of the speaker, as well 
as the topic being addressed. Written comments should not exceed one 
single-spaced typed page in length and delivered in three minutes or 
less. Please note that the public comment period may end before the 
time indicated, following the last call for comments. Members of the 
public who wish to provide public comments should plan to attend the 
public comment session at the start time listed. Written comments 
received in advance of the meeting will be included in the official 
record of the meeting.
    The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html
    Purpose: The committee is charged with advising the Director, CDC, 
on the appropriate use of immunizing agents. In addition, under 42 
U.S.C. 1396s, the committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines. 
Further, under provisions of the Affordable Care Act, at section 2713 
of the Public Health Service Act, immunization recommendations of the 
ACIP that have been adopted by the Director of the Centers for Disease 
Control and Prevention must be covered by applicable health plans.
    Matters for discussion: The agenda will include discussions on: 
Meningococcal vaccines; general recommendations; human papillomavirus 
vaccines; influenza; influenza A(H5N1) vaccine, tetanus, diphtheria, 
and acellular pertussis (Tdap) vaccine; combination vaccines; smallpox 
vaccine in laboratory personnel; pneumococcal vaccines; child/
adolescent immunization schedule; herpes zoster vaccines; Japanese 
encephalitis vaccine and vaccine supply. Recommendation votes are 
scheduled for meningococcal vaccines, influenza, influenza A (H5N1), 
smallpox vaccine in laboratory personnel, general recommendations and 
pneumococcal vaccines. A Vaccines for Children (VCF) vote is scheduled 
for meningococcal vaccines.
    Agenda items are subject to change as priorities dictate.
    Contact person for more information: Stephanie Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road NE., MS-A27, Atlanta, Georgia 30333, telephone 404/639-8836; Email 
[email protected]
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-13312 Filed 6-1-15; 8:45 am]
 BILLING CODE 4160-18-P